NEW YORK (GenomeWeb News) – The National Cancer Institute has extended an existing agreement with synthetic genomics company GeneArt to produce genes for the NCI’s Mammalian Gene Collection, the company said today.
 
GeneArt said that it stands to gain an additional $800,000 from the expanded contract, bringing the total value of the agreement to $2.7 million in 2008.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.